Mootaz M Salman Selected Research

Mootaz M Salman Research Topics

3	Stroke (Strokes) 12/2023 - 07/2015
3	Brain Edema (Cerebral Edema) 12/2023 - 07/2015
2	Edema (Dropsy) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 01/2020 - 01/2017
2	Hypothermia 11/2017 - 01/2017
1	Cerebral Malaria 12/2022
1	Huntington Disease (Huntington's Disease) 04/2021
1	Alzheimer Disease (Alzheimer's Disease) 04/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2021
1	Parkinson Disease (Parkinson's Disease) 04/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2020
1	Neuromyelitis Optica (Devic's Disease) 03/2019
1	Epilepsy (Aura) 09/2017
1	Temporal Lobe Epilepsy 09/2017
1	Brain Injuries (Brain Injury) 01/2017
1	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2015

3	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2017
3	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2021 - 11/2017
2	Aquaporins (Water Channels)IBA 12/2023 - 09/2017
2	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2020 - 11/2017
2	Aquaporin 4IBA 11/2017 - 07/2015
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2021
1	Immunoglobulin G (IgG)IBA 03/2019
1	EGTA acetoxymethyl esterIBA 11/2017
1	N- (1- ((4- (2- (((2,4- dichlorophenyl)sulfonyl)amino)- 3- hydroxypropanoyl)- 1- piperazinyl)carbonyl)- 3- methylbutyl)- 1- benzothiophene- 2- carboxamideIBA 11/2017
1	CalciumIBA 11/2017
1	Calcium Channels (Calcium Channel)IBA 11/2017
1	HC-067047IBA 11/2017

2	Therapeutics 01/2021 - 01/2020
1	Induced Hypothermia 01/2017